A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.
Saved in:
| Title: | A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects. |
|---|---|
| Authors: | Yurgelun-Todd, Deborah A.1 (AUTHOR) Deborah.Yurgelun-Todd@hsc.utah.edu, Renshaw, Perry F.1 (AUTHOR), Goldsmith, Paul2 (AUTHOR), Uz, Tolga3 (AUTHOR), Macek, Thomas A.3 (AUTHOR) |
| Source: | Psychopharmacology. Feb2020, Vol. 237 Issue 2, p317-328. |
| Database: | SPORTDiscus with Full Text |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00333158 |
|---|---|
| DOI: | 10.1007/s00213-019-05366-1 |
